Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Tuesday, September 30, 2025Genmab AS and Merus NV announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus a clinicalstage biotechnology company with its latestage breakthrough therapy asset petosem...
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
Thursday, September 25, 2025Hansa Biopharma ABtoday announced positive topline results from the US Phase ConfIdeS trial of imlifidase evaluating month kidney function in highly sensitized cPRA adult kidney transplant patients
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
Thursday, September 25, 2025Hengrui Pharmaa leading innovative global pharmaceutical company focused on scientific and technological innovation announced today that it has entered into an exclusive license agreement with Glenmark Specialty SA
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Wednesday, September 24, 2025Sanofi Ventures has announced an additional million multiyear capital commitment from Sanofi increasing its total assets under management to over billion This new commitment to the evergreen
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development
Wednesday, September 24, 2025BioLegacy Evaluative Group Inc a whollyowned subsidiary of Branded Legacy Inc OTC BLEG and an emerging leader in life sciences innovation proudly announces the official opening of its stateoftheart squarefoot Good Manufacturing
Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease
Tuesday, September 23, 2025Bayer announced today progress for two potential therapies against Parkinsons disease PD A first participant received randomized treatment in the pivotal Phase III clinical trial exPDite of bemdaneprocel
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
Tuesday, September 23, 2025Idorsia Ltd announces that Simcere Pharmaceuticals Group Ltd HK Simcere has launched QUVIVIQ daridorexant in China QUVIVIQ Idorsias dual orexin receptor antagonist is indicated for the treatment
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
Friday, September 19, 2025Vertex Pharmaceuticalsannounced today a reimbursement agreement with the Italian Medicines Agency AIFA for eligible transfusiondependent beta thalassemia TDT and severe sickle cell disease SCD patients
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Thursday, September 18, 2025Biogen Incannounced that the European Commission EC has granted marketing authorization for ZURZUVAE zuranolone to treat postpartum depression PPD in adults following childbirth ZURZUVAE
Biocytogen announces that ADC innovator Tubulis has signed a worldwide exclusive license agreement for a single antibody
Thursday, September 18, 2025Biocytogen Pharmaceuticals Co Ltda global biotechnology company advancing the research and development of novel antibody therapeutics with innovative technologies today announced that ADC developer
